期刊文献+

细胞因子诱导的杀伤细胞体外培养的初步研究(英文) 被引量:1

Preliminary study on the culture method of cytokines induced killer cells
原文传递
导出
摘要 Objective To investigate the culture method of cytokines induced killer cells using CD3 monoclonal antibody,IL-2,IFN-γ and IL-1α in vitro.Methods Peripheral blood mononuclear cells (PBMC) were collected by a blood cell separator from 8 patients with refractory lymphoma,then expanded by priming them with recombinant IFN-γ,monoclonal antibody (mAb) to CD3 and human recombinant IL-1α,followed by adding recombinant IL-2 the next day.The CIK cells were counted on d1,4,7,10,13 of incubation,respectively.The phenotypic patterns were characterized before culture and on d13 of culture.Results CIK cells colony formed on d3.On d13,the CIK cells counting reached up to (7-18)×109(mean 12.7×109),multiplying 44-140 times(mean 98 times).Cell survival rate was over 90%.The average percentage of cells expressing CD3+,CD4+,CD8+ and CD3+ CD56+ were also increased from (50.9±3.5)%,(29.9±1.7)%,(41.3±3.2)%,(1.6±0.2)% to (90.2±1.6)%,(40.6±5.5)%,(52.8±4.9)% and (33.1±4.0)%,respectively.Conclusions CIK cells developed by the culture method have high in vitro proliferate rate and tumor-killing capacity.The simplicity of the operation and autogenic source of the cells indicate the method could be applied clinically treating patients with refractory lymphoma. Objective To investigate the culture method of cytokines induced killer cells using CD3 monoclonal antibody,IL-2,IFN-γ and IL-1α in vitro.Methods Peripheral blood mononuclear cells (PBMC) were collected by a blood cell separator from 8 patients with refractory lymphoma,then expanded by priming them with recombinant IFN-γ,monoclonal antibody (mAb) to CD3 and human recombinant IL-1α,followed by adding recombinant IL-2 the next day.The CIK cells were counted on d1,4,7,10,13 of incubation,respectively.The phenotypic patterns were characterized before culture and on d13 of culture.Results CIK cells colony formed on d3.On d13,the CIK cells counting reached up to (7-18)×109(mean 12.7×109),multiplying 44-140 times(mean 98 times).Cell survival rate was over 90%.The average percentage of cells expressing CD3+,CD4+,CD8+ and CD3+ CD56+ were also increased from (50.9±3.5)%,(29.9±1.7)%,(41.3±3.2)%,(1.6±0.2)% to (90.2±1.6)%,(40.6±5.5)%,(52.8±4.9)% and (33.1±4.0)%,respectively.Conclusions CIK cells developed by the culture method have high in vitro proliferate rate and tumor-killing capacity.The simplicity of the operation and autogenic source of the cells indicate the method could be applied clinically treating patients with refractory lymphoma.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第21期6318-6321,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 Killer cells Culture technique Preparation technic cytohistological AMPLIFICATION Killer cells Culture technique Preparation technic,cytohistological Amplification
  • 相关文献

参考文献12

  • 1A. Gritzapis,D. Dimitroulopoulos,E. Paraskevas,C. Baxevanis,M. Papamichail.Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants[J]. Cancer Immunology, Immunotherapy . 2002 (8)
  • 2Li H,Wang C,Yu J,et al.Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy . 2009
  • 3Kuci S,Rettinger E,Voss B,et al.Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunother- apy after allogeneic stem cell transplantation. Haematologica . 2010
  • 4Jiang YH,Cheng B,Ge MH,et al.Comparison of the clinical and immunohistochemical features,including anaplastic lymphoma kinase ( ALK) and p53,in inflammatory myofibroblastic tumours. Journal of International Medical Research . 2009
  • 5Nishimura R,Baker J,Beilhack A,et al.In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of anti-tumor activity. Blood . 2008
  • 6Sangiolo D,Martinuzzi E,Todorovic M,et al.Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer ( CIK) cells: implications for their infusion across major HLA barriers. International Immunology . 2008
  • 7Introna M,Pievani A,Borleri G,et al.Feasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantation. Biology of Blood and Marrow Transplantation . 2010
  • 8Bonanno G,Iudicone P,Mariotti A,et al.Thymoglobulin,interferon-γ and interleukin-2 efficiently expand cytokine-induced killer ( CIK) cells in clinical-grade cultures. Journal of Translational Medicine . 2010
  • 9Schmidt-Wolf IG,Negrin RS,Kiem HP,et al.Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. The Journal of Experimental Medicine . 1991
  • 10Linn YC,Hui KM.Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leukemia and Lymphoma . 2003

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部